The present study elucidated for the first time that TIPE2 is downregulated in the progression of cardiac hypertrophy to heart failure and that TIPE2 overexpression inhibits pressure overload-induced cardiac hypertrophy, fibrosis, and dysfunction. Here, TIPE2 is linked to cardiac hypertrophy.